adxs-504
Generic: Listeria monocytogenes-LLO-Prostate Cancer Neoantigens Vaccine ADXS-504·Code: ADXS-504
adxs-504: developed by 2 companies. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| OLD AYALA, INC (AYLA) | Phase 1 |
| OS Therapies Inc (OSTX) | Preclinical |
Get deeper analysis on adxs-504
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis